Contact TALLC

Get In Touch

7 + 9 =

More Info

We are a pre-clinical stage pharmaceutical company using our proprietary NCE to treat acute and chronic inflammation. We will offer our products for licensing post Ph II studies in high unmet need indications.

Address: 500 Cartier Blvd W
Laval (Québec)
Canada H7V 5B7

Phone: 514 883 3447


Phone: 514 883 3447



TALLC Corporation Announces Grant of New SmartCelle Patent for
Enhanced Ocular Delivery of TA-A001

Tetra Bio-Pharma and Altus Formulation Form New Company “TALLC” to Exploit TA-A001

TALLC Innovation in Vision

© TALLC Inc. 2020